ESS BDP glucocorticoid receptor, GR BDP BACKGROUND : Eosinophilic chronic rhinosinusitis ECRS is characterized by nasal polyposis and mucosal eosinophilic infiltration. Although the local or systemic administration of glucocorticoids is considered to be a potent treatment strategy for preventing the relapse of nasal polyposis, its efficacy remains controversial.
OBJECTIVE : The aim of the study was to examine whether the presence of bronchial asthma may influence the therapeutic efficacy of postoperative treatment with the topical application of beclomethasone dipropionate BDP dry powder in ECRS patients. The histological features of the local expression of glucocorticoid receptor isoforms in the paranasal sinus mucosa were also observed.
STUDY DESIGN : Twenty patients with ECRS and with or without bronchial asthma who underwent endoscopic sinus surgery ESS at Hiroshima University Hospital were examined. All the patients had received postoperative treatment with the topical application of BDP dry powder. The therapeutic effects were evaluated based on the endoscopic findings and the computed tomography CT scores.
RESULTS :
The overall remission rate as assessed using nasal endoscopy was 87%. The degree of improvement in the postoperative endoscopy score was less in asthmatic patients, compared with non asthmatic patients, and the difference was statistically significant p 0 01 . The average of the total sinus CT scores decreased remarkably from 9 4 to 3 2 after treatment with topical BDP application. The postoprative CT scores remained higher in asthmatic patients as compared with non asthmatic patients 3 9 vs. 2 1, p 0 05 . The immunohistological expression of GRβ was mainly observed in the inflammatory cells of the ethmoid sinus mucosa.
CONCLUSION ;
The present results reveal that postoperative treatment with the topical application of BDP dry powder is effective for controlling the inflammatory process that persists in the sinonasal cavity after surgery. The remission rate was higher in asthmatic paatients as compared with non asthmatic patients.
Thus, after endoscopic sinus surgery, patients with bronchial asthma require certain additional treatment. 
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